Critical Limb Ischemia clinical trials at UCLA
1 research study open to eligible people
Showing trials for
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
open to eligible people ages 18-95
A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.
Torrance, California and other locations
Our lead scientists for Critical Limb Ischemia research studies include Mark Archie.